Registration number: 14376321

Biosurv International Ltd

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 7

Biosurv International Ltd

Company Information

Director

Ms C B Pratt

Registered office

The Lyle Building Porton Science Park, Clewer Road Porton Down Salisbury Wiltshire SP4 0DQ

Accountants

Numeric Accounting Chartered Certified AccountantsSuite 1 The Portway Centre Old Sarum Park Old Sarum Salisbury Wiltshire SP4 6EB

Biosurv International Ltd

(Registration number: 14376321)
Balance Sheet as at 30 September 2024

	Note	2024 £	2023 £
Fixed assets
Tangible assets	4	21,312	1,068
Current assets
Debtors	5	8,526	1,705
Cash at bank and in hand		387,258	34,170
		395,784	35,875
Creditors: Amounts falling due within one year	6	(149,207)	(34,811)
Net current assets		246,577	1,064
Net assets		267,889	2,132
Reserves
Other reserves		267,889	2,132
Surplus		267,889	2,132

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 19 June 2025
 

......................................... Ms C B Pratt Director

Biosurv International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

1	General information

The company is a company limited by guarantee, incorporated in United Kingdom, and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £Nil towards the assets of the company in the event of liquidation.

The address of its registered office is:
The Lyle Building Porton Science Park,
Clewer Road
Porton Down
Salisbury
Wiltshire
SP4 0DQ

These financial statements were authorised for issue by the director on 19 June 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Biosurv International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024 (continued)

2	Accounting policies (continued)

Other grants

Grant income is recognized in the financial statements when there is reasonable assurance that the conditions attached to the grant will be met and that the grant will be received. Revenue grants are recognized in the statement of profit or loss on a systematic basis over the period in which the related costs are incurred. Capital grants are initially recognized as deferred income in the statement of financial position and are subsequently transferred to the statement of profit or loss over the useful life of the asset to which they relate. Where grants are received in advance of meeting the conditions, they are recognized as deferred income until the conditions are satisfied.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Computer Equipment	33% Straight Line
Plant and Machinery	25% & 12.50% Straight Line

Biosurv International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024 (continued)

2	Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
A financial instrument is a contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.
 Recognition and measurement
When a financial asset or financial liability is recognised initially, the entity shall measure it at the transaction price unless the arrangement constitutes, in effect, a financing transaction. An arrangement constitutes a financing transaction if payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

At the end of each reporting period, an entity shall measure all financial instruments which constitute a financing arrangement at fair value and recognise changes in fair value in profit or loss.
 

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2023 - 1).

Biosurv International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024 (continued)

4	Tangible assets

	Plant and machinery £	Computer equipment £	Total £
Cost or valuation
At 1 October 2023	-	1,479	1,479
Additions	17,659	5,342	23,001
At 30 September 2024	17,659	6,821	24,480
Depreciation
At 1 October 2023	-	411	411
Charge for the year	1,083	1,674	2,757
At 30 September 2024	1,083	2,085	3,168
Carrying amount
At 30 September 2024	16,576	4,736	21,312
At 30 September 2023	-	1,068	1,068

5

Debtors

Current	2024 £	2023 £
Prepayments	4,949	336
Other debtors	3,577	1,369
	8,526	1,705

6

Creditors

Creditors: amounts falling due within one year

Biosurv International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024 (continued)

6	Creditors (continued)

	2024 £	2023 £
Due within one year
Trade creditors	16,115	12,586
Taxation and social security	3,471	6,935
Accruals and deferred income	112,984	1,420
Other creditors	16,637	13,870
	149,207	34,811

7

Reserves

Other reserves are non-distributable and they are held for reinvestment in future projects and as working capital.

8	Related party transactions

Transactions with the director

2024	At 1 October 2023 £	Other payments made to company by director £	At 30 September 2024 £
Ms C B Pratt
The loan is interest free with no fixed date of repayment.	(13,870)	(554)	(14,424)